Unlock stock picks and a broker-level newsfeed that powers Wall Street.
30 Countries with the Highest Depression Rates

In This Article:

In this piece, we will take a look at 30 countries with the highest depression rates. For more countries, head on over to 5 Countries with the Highest Depression Rates.

Despite humankind's technological progress, the age-old question of whether money buys happiness is still often on everyone's minds. This query pops up more during times of economic turmoil such as last year when inflation soared to a record high. And its answer depends on who you ask. For instance, most people who struggle with their monthly bills will give a strong and resounding 'yes', while others, such as the billionaire Warren Buffett of Berkshire Hathaway Inc. (NYSE:BRK-A), believe that there is more to life than money, with the greatest sources of pleasure for Mr. Buffett being the satisfaction that he finds in his work and spending time with his loved ones.

Additionally, advances in modern day medical science have allowed humans to categorize and treat more diseases than previously thought. One of the newer fields of today's medicine is depression and mental health disorders. While the term depression was coined in the 14th century, the earliest theories studying the cause of the disease were more philosophical in nature. In fact, it wasn't until the mid 1900s that researchers were able to determine that depression is caused by imbalances of neurotransmitters in the brain. The most common neurotransmitter that is related to depression is serotonin and medications to fight the disease often work by trying to increase its level in the brain.

Anxiety and Depression Treatment Industry

Estimates from the World Health Organization (WHO) suggest that at least 280 million people suffer from depression all over the world. Women are far more likely to be depressed than men, and depression truly is a deadly disease as it can also lead to a loss of life through suicide. The huge number of depression patients also opens up a large market for treatments. According to research from Emergen Research, the global anxiety and depression treatment market was worth $12.06 billion in 2019 and is set to grow through a compounded annual growth rate (CAGR) of 3.9% between then and 2027 to sit at an estimated $16 billion by the end of the forecast period. The research firm believes that the market will grow due to higher diagnosis and testing as well as people who currently use medicines to develop a tolerance for them. Additionally, it also outlines that within the market, antidepressants held the highest share, as they commanded 63.9% of all sales in 2019.